Search

Search for a security

Results

Equities (17)
CompanySymbolExchangeCountry
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd2566:HKGHong Kong Stock ExchangePrimaryHong Kong
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd2566:HKG.HSHong Kong Stock ExchangeHong Kong
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd2566:HKG.HZHong Kong Stock ExchangeHong Kong
Hanx Biopharmaceuticals (Wuhan) Co Ltd3378:HKGHong Kong Stock ExchangePrimaryHong Kong
Hanx Biopharmaceuticals (Wuhan) Co Ltd3378:HKG.HZHong Kong Stock ExchangeHong Kong
Hanx Biopharmaceuticals (Wuhan) Co Ltd3378:HKG.HSHong Kong Stock ExchangeHong Kong
Tian'an Pharmaceutical Co LtdTNPH:PKLOTC Markets Group Inc - Limited InformationPrimaryUnited States
Hansa Biopharma ABHNSA:STONASDAQ STOCKHOLM AB (STO)PrimarySweden
Hansa Biopharma AB0RC7:LSELondon Stock ExchangeUnited Kingdom
Hansa Biopharma AB24H:STUStuttgart Stock ExchangeGermany
Hansa Biopharma AB24H:FRAGerman Stock ExchangeGermany
Hansa Biopharma AB24H:MUNMunich Stock ExchangeGermany
Hansa Biopharma AB24H:DUSDusseldorf Stock ExchangeGermany
Hangzhou Biotest Biotech Co Ltd688767:SHHShanghai Stock ExchangePrimaryChina
Hangzhou Biotest Biotech Co Ltd688767:SHH.SHShanghai Stock ExchangeChina
Hangzhou Alltest Biotech Co Ltd688606:SHHShanghai Stock ExchangePrimaryChina
Hangzhou Alltest Biotech Co Ltd688606:SHH.SHShanghai Stock ExchangeChina
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.